Aspirin use ‘cuts risk of death from prostate cancer by more than half’
October 26th, 2010 - 12:27 pm ICT by ANIWashington, Oct 26 (ANI): A new study has suggested that men with prostate cancer who take anticoagulants like aspirin in addition to radiation therapy or surgery may be able to cut their risk of dying of the disease by more than half.
“Evidence has shown that anticoagulants may interfere with cancer growth and spread,” Kevin Choe, lead author of the study and a radiation oncologist at University of Texas Southwestern Medical School in Dallas, said.
Researchers evaluated data from the Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) database to investigate the effect of anticoagulation medications (aspirin, warfarin, clopidogrel and/or enoxaparin) on the risk of dying from prostate cancer among men whose cancer has not metastasized.
The study involved 5,275 men whose cancer had not spread beyond the prostate gland (localized prostate cancer) and were treated with surgery or radiation, two of the most common treatment modalities for prostate cancer. Of these patients, 1,982 were taking anticoagulants. Patients were classified as having high-, intermediate- or low-risk disease.
Results of the study show that the use of anticoagulants among prostate cancer patients treated with either surgery or radiation reduced the risk of dying from the disease from 10 percent to 4 percent at 10 years. The risk of developing bone metastasis was also reduced. In addition, findings reveal that the benefit appeared even greater among patients diagnosed with high-risk prostate cancer.
The study also found that the benefit was most prominent with aspirin, compared to other anticoagulants.
The study will be presented on November 3, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.(ANI)
- Aspirin cuts prostate cancer risk - Oct 27, 2010
- 'Watchful waiting' often best strategy for low-risk prostate cancer - Jun 19, 2010
- Aspirin reduces risk of cancer recurrence in prostate cancer patients - May 03, 2011
- Prostate cancer screening improves patients' quality of life - Oct 26, 2010
- Aspirin safer than warfarin in preventing stroke: Study - May 03, 2012
- Exercise improves survival in prostate cancer patients - Feb 02, 2012
- Daily aspirin cuts bowel cancer death risk - Apr 26, 2012
- Aspirin reduces prostate cancer risk by 30 percent - Aug 13, 2010
- Taking aspirin daily 'cuts prostate cancer risk by 30pc' - Aug 12, 2010
- New drug busts clot risks in joint replacement - Sep 19, 2011
- Biomarker-based blood test can predict metastasis risk in melanoma - Apr 16, 2011
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- Reports of problems with blood-thinner wrong: study - Aug 30, 2010
- Faulty gene spikes prostate cancer risk in men - Apr 22, 2012
Tags: anticoagulation, bone metastasis, cancer growth, clopidogrel, enoxaparin, prostate cancer, prostate cancer patients, prostate gland, radiation oncologist, radiation oncology, radiation therapy, research endeavor, risk disease, southwestern medical school, study also found that, texas southwestern medical, texas southwestern medical school, treatment modalities, university of texas southwestern medical school, urological research